Publications by authors named "Ann Woolfrey"

Claim this Profile
A
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Jason P Cooper, Barry E Storer, Noa Granot, Boglark Gyurkocza, Mohamed L Sorror, Ann E Woolfrey

Haematologica· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.
Vikas Gupta, Soyoung Kim, Zhen-Huan Hu, Ying Liu, Mahmoud Aljurf, Ann Woolfrey

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Brian Kornblit, Barry E Storer, Niels S Andersen, Michael B Maris, Thomas R Chauncey, Ann E Woolfrey

Blood· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
Kanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, Haydar A Frangoul, Troy R Torgerson, Ann E Woolfrey

Biol Blood Marrow Transplant· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
Daniel Weisdorf, Sarah Cooley, Tao Wang, Elizabeth Trachtenberg, Cynthia Vierra-Green, Ann E Woolfrey

Blood Adv· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.
Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, Jean-Hugues Dalle, Ann E Woolfrey

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Nelli Bejanyan, Soyoung Kim, Kyle M Hebert, Natasha Kekre, Hisham Abdel-Azim, Ann E Woolfrey

Blood Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children.
Ann Dahlberg, Wendy Leisenring, Marie Bleakley, Soheil Meshinchi, K Scott Baker, Ann Woolfrey

Bone Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Brenda M Sandmaier, Brian Kornblit, Barry E Storer, Gitte Olesen, Michael B Maris, Ann E Woolfrey

Lancet Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
Simon Pahnke, Torstein Egeland, Jörg Halter, Hans Hägglund, Bronwen E Shaw, Ann E Woolfrey

Bone Marrow Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
Mahmoud Elsawy, Barry E Storer, Filippo Milano, Brenda M Sandmaier, Colleen Delaney, Ann E Woolfrey

Biol Blood Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.
Ann Woolfrey, Tao Wang, Stephanie J Lee, Michael D Haagenson, Ge Chen

Bone Marrow Transplant· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Monica S Thakar, Larisa Broglie, Brent Logan, Andrew Artz, Nancy Bunin, Ann Woolfrey

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR Donor Selection: Feasibility in Identifying better Donors.
Daniel Weisdorf, Sarah Cooley, Tao Wang, Elizabeth Trachtenberg, Michael D Haagenson, Ann Woolfrey

Biol Blood Marrow Transplant· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A.
Jennifer E Adair, Devikha Chandrasekaran, Gabriella Sghia-Hughes, Kevin G Haworth, Ann E Woolfrey

Haematologica· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Ann E Woolfrey

Blood Adv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
Jonathan L Golob, Joshua Stern, Sarah Holte, Mari M Kitahata, Heidi M Crane, Ann E Woolfrey

AIDS· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.
Bronwen E Shaw, Brent R Logan, Stephen R Spellman, Steven G E Marsh, James Robinson, Ann Woolfrey

Biol Blood Marrow Transplant· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.
Rajinder P S Bajwa, Kris M Mahadeo, Benjamin H Taragin, Christopher C Dvorak, Jennifer McArthur, Ann E Woolfrey

Biol Blood Marrow Transplant· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
Lauri M Burroughs, Akiko Shimamura, Julie-An Talano, Jennifer A Domm, Kelsey K Baker, Ann E Woolfrey

Biol Blood Marrow Transplant· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.
Menachem Bitan, Kwang Woo Ahn, Heather R Millard, Michael A Pulsipher, Hisham Abdel-Azim, Ann Woolfrey

Biol Blood Marrow Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study.
Sandeep Soni, Hisham Abdel-Azim, Meghann McManus, Eneida Nemecek, Richard Sposto, Ann Woolfrey

Biol Blood Marrow Transplant· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.
Christopher W Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E McAllister, Ann E Woolfrey

JCI Insight· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.
Stephanie J Lee, Brent Logan, Peter Westervelt, Corey Cutler, Ann Woolfrey

JAMA Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cord-Blood Transplantation in Patients with Minimal Residual Disease.
Filippo Milano, Ted Gooley, Brent Wood, Ann Woolfrey, Mary E Flowers

N Engl J Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis